A survey by the Fondation ARC revealed that 78% of respondents aged 65 and older in France expressed high expectations for AI's therapeutic potential in cancer diagnosis, contrasting with 60% of those under 35 who perceive AI as merely a 'gadget'. This divergence in perspectives highlights a critical generational gap in trust towards AI technologies, where younger individuals seem more aware of potential risks such as algorithm biases and misdiagnoses. Instead of outright rejection, their caution may stem from a critical approach to technology, resulting in what is observed as conditional trust rather than ignorance of technology.

Despite the growing adoption of AI in French hospitals, where approximately 65% are reportedly using AI solutions, public awareness of AI's presence in healthcare remains low. The FHF (French Hospital Federation) anticipates further AI project implementations in the coming years, with 90% of surveyed hospitals planning to introduce additional AI initiatives. However, as indicated by the Fondation ARC survey, 67% of respondents are unaware of AI's current role in their hospitals, showcasing a disconnect between technological advancements in healthcare and public knowledge about these changes.

This gap poses a significant challenge for the integration of medical AI, emphasizing that the effort should focus more on building trust among patients rather than merely implementing new technologies. As many as 40% of survey participants still hesitate to endorse the application of AI in cancer diagnosis and treatment, indicating a need for educational initiatives that clarify AI's capabilities and address public concerns about its risks, thereby fostering a more informed acceptance of medical AI solutions in clinical settings.